Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion for Smoking Cessation in Schizophrenia
NCT00307203Phase 4Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Aug 1998
- Primary completion
- Feb 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupropion in Tobacco Use Disorder (TUD), sponsored by National Institute on Drug Abuse. Started Aug 1998; status: completed.
02
Drugs
bupropion
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00307203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00307203.